Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC716421715;21716;21717 chr2:178723610;178723609;178723608chr2:179588337;179588336;179588335
N2AB684720764;20765;20766 chr2:178723610;178723609;178723608chr2:179588337;179588336;179588335
N2A592017983;17984;17985 chr2:178723610;178723609;178723608chr2:179588337;179588336;179588335
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCT
  • RefSeq wild type template codon: GGA
  • Domain: Ig-56
  • Domain position: 28
  • Structural Position: 42
  • Q(SASA): 0.2837
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/A rs927054837 None 0.248 D 0.273 0.443 0.270889551736 gnomAD-4.0.0 1.36911E-05 None None None None I None 0 0 None 0 0 None 0 0 1.79939E-05 0 0
P/L rs981191810 -0.075 0.961 D 0.593 0.51 None gnomAD-2.1.1 8.08E-06 None None None None I None 0 0 None 0 0 None 0 None 0 1.79E-05 0
P/L rs981191810 -0.075 0.961 D 0.593 0.51 None gnomAD-3.1.2 1.31E-05 None None None None I None 4.83E-05 0 0 0 0 None 0 0 0 0 0
P/L rs981191810 -0.075 0.961 D 0.593 0.51 None gnomAD-4.0.0 3.84664E-06 None None None None I None 3.38444E-05 0 None 0 0 None 0 0 2.3946E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.0734 likely_benign 0.0806 benign -0.48 Destabilizing 0.248 N 0.273 neutral D 0.52327237 None None I
P/C 0.5174 ambiguous 0.5858 pathogenic -0.752 Destabilizing 1.0 D 0.649 neutral None None None None I
P/D 0.4886 ambiguous 0.5208 ambiguous -0.393 Destabilizing 0.942 D 0.473 neutral None None None None I
P/E 0.2465 likely_benign 0.2716 benign -0.484 Destabilizing 0.503 D 0.289 neutral None None None None I
P/F 0.3746 ambiguous 0.4381 ambiguous -0.673 Destabilizing 0.999 D 0.65 neutral None None None None I
P/G 0.3424 ambiguous 0.3804 ambiguous -0.596 Destabilizing 0.97 D 0.51 neutral None None None None I
P/H 0.1726 likely_benign 0.1878 benign -0.032 Destabilizing 1.0 D 0.565 neutral D 0.642424165 None None I
P/I 0.2694 likely_benign 0.3109 benign -0.308 Destabilizing 0.991 D 0.633 neutral None None None None I
P/K 0.2244 likely_benign 0.2468 benign -0.475 Destabilizing 0.97 D 0.46 neutral None None None None I
P/L 0.0987 likely_benign 0.115 benign -0.308 Destabilizing 0.961 D 0.593 neutral D 0.605045657 None None I
P/M 0.2688 likely_benign 0.3126 benign -0.59 Destabilizing 1.0 D 0.561 neutral None None None None I
P/N 0.3684 ambiguous 0.4088 ambiguous -0.309 Destabilizing 0.996 D 0.546 neutral None None None None I
P/Q 0.1331 likely_benign 0.144 benign -0.503 Destabilizing 0.991 D 0.481 neutral None None None None I
P/R 0.1338 likely_benign 0.1462 benign 0.016 Stabilizing 0.989 D 0.541 neutral D 0.626001196 None None I
P/S 0.108 likely_benign 0.1181 benign -0.642 Destabilizing 0.925 D 0.446 neutral D 0.538400884 None None I
P/T 0.1092 likely_benign 0.1272 benign -0.633 Destabilizing 0.433 N 0.289 neutral D 0.580729089 None None I
P/V 0.1866 likely_benign 0.2154 benign -0.335 Destabilizing 0.97 D 0.511 neutral None None None None I
P/W 0.5636 ambiguous 0.6151 pathogenic -0.745 Destabilizing 1.0 D 0.651 neutral None None None None I
P/Y 0.3553 ambiguous 0.399 ambiguous -0.466 Destabilizing 0.999 D 0.649 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.